Log in
Log in

  • Home
  • Maintaining the momentum: Hepatitis C and HIV in the context of harm reduction

Maintaining the momentum: Hepatitis C and HIV in the context of harm reduction

  • 28 Sep 2022
  • 3:00 PM - 4:30 PM
  • Webinar

The landscape of drug use is changing in Canada due to shifting drug use patterns, inequitable access to harm reduction services and an ongoing drug poisoning crisis driven by a toxic drug supply, punitive drug laws and stigma. The current situation is causing incredible harm to people who use drugs and has placed a significant strain on people providing harm reduction services.

Hepatitis C and HIV disproportionately affect people who use drugs in Canada. It is essential that we understand evolving drug use patterns and how they relate to HIV or hepatitis C acquisition, and how harm reduction services can support the health of people who use drugs.  

This webinar will provide a pan-Canadian snapshot of hepatitis C, HIV and drug use trends among people who use drugs. A panel of discussants will explore ways to maintain the momentum in Canada’s response to hepatitis C and HIV in the context of the overdose crisis.   

Moderator: Shelley Taylor, Specialist, Education and Capacity Building, CATIE


  • Chris Fraser, MD, Medical Director, Victoria Cool Aid Society 
  • Kayla DeMong, Executive Director, Prairie Harm Reduction
  • Kate Harland, RN, Vice President, Harm Reduction Nurses Association
  • Camille Arkell, Manager, HIV and Harm Reduction, CATIE

Register Here

Copyright 2017 - Public Health Physicians of Canada  /  Médecins de santé publique du Canada

Site by Merge Creative Inc.

Powered by Wild Apricot Membership Software